These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19770786)

  • 1. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness.
    Lopez SA; Mulla H; Durward A; Tibby SM
    Pediatr Crit Care Med; 2010 Mar; 11(2):267-74. PubMed ID: 19770786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
    McDade EJ; Wagner JL; Moffett BS; Palazzi DL
    Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
    Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
    J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a dosage individualization table for extended-interval gentamicin in neonates.
    Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K
    Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.
    Cooper AC; Commers AR; Finkelstein M; Lipnik PG; Tollefson LM; Wilcox RA; Hoff DS
    Pharmacotherapy; 2011 Jul; 31(7):649-57. PubMed ID: 21923451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily gentamicin dosing in full term neonates.
    Alsaedi SA
    Saudi Med J; 2003 Sep; 24(9):978-81. PubMed ID: 12973482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
    Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
    Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
    Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
    J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose.
    Gonçalves-Pereira J; Martins A; Póvoa P
    Clin Microbiol Infect; 2010 Aug; 16(8):1258-63. PubMed ID: 19832713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation.
    Ghoneim RH; Thabit AK; Lashkar MO; Ali AS
    Ital J Pediatr; 2021 Aug; 47(1):167. PubMed ID: 34362436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-interval gentamicin administration in malnourished children.
    Khan AM; Ahmed T; Alam NH; Chowdhury AK; Fuchs GJ
    J Trop Pediatr; 2006 Jun; 52(3):179-84. PubMed ID: 16126804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.
    Xuan D; Nicolau DP; Nightingale CH
    Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates.
    Begg EJ; Vella-Brincat JW; Robertshawe B; McMurtrie MJ; Kirkpatrick CM; Darlow B
    J Antimicrob Chemother; 2009 May; 63(5):1043-9. PubMed ID: 19299469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
    Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A
    Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.